Trials / Terminated
TerminatedNCT02003872
The Long Term Effect of Adjustable Spaatz 3 Intragastric Balloon on Weight Loss
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label trial investigating the effect of Spatz 3 intragastric balloon on weight loss on obesity and associated co- morbidities. The study aim is to evaluate the effect of the intra gastric balloon on weight reduction and on related co- morbidities during 1 year of balloon implantation and a year following explantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spatz 3 intragastric balloon | Intra gastric balloon implanted using gastroscopy |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2013-12-06
- Last updated
- 2015-12-22
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02003872. Inclusion in this directory is not an endorsement.